Drug Shortage Report for RESONIUM CALCIUM

Last updated on 2021-04-06 History
Report ID 134202
Drug Identification Number 02017741
Brand name RESONIUM CALCIUM
Common or Proper name Resonium Calcium
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) CALCIUM POLYSTYRENE SULFONATE
Strength(s) 999MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration ORAL RECTAL ORAL RECTAL
Packaging size 1
ATC code V03AE
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-02-10
Actual start date
Estimated end date 2021-04-23
Actual end date
Shortage status Actual shortage
Updated date 2021-04-06
Company comments Overselling - Shipping Delay The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-04-06 French Compare
v7 2021-04-06 English Compare
v6 2021-03-11 French Compare
v5 2021-03-11 English Compare
v4 2021-02-16 French Compare
v3 2021-02-16 English Compare
v2 2021-02-16 French Compare
v1 2021-02-16 English Compare